Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism
Alessandro Bonifazi, Hideaki Yano, Michael P. Ellenberger, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 7, pp. 2890-2907
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Biased Receptor Signaling in Drug Discovery
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 249
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential
Mohammad Seyedabadi, Mohammad Hossein Ghahremani, Paul R. Albert
Pharmacology & Therapeutics (2019) Vol. 200, pp. 148-178
Closed Access | Times Cited: 135
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan, Wenzhong Yan, John D. McCorvy, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9841-9878
Closed Access | Times Cited: 122
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds
Amy E. Moritz, R. Benjamin Free, David R. Sibley
Cellular Signalling (2017) Vol. 41, pp. 75-81
Open Access | Times Cited: 56
Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists
Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 1, pp. 52-65
Open Access | Times Cited: 50
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sánchez‐Soto, Ravi Kumar Verma, Blair K. A. Willette, et al.
Science Signaling (2020) Vol. 13, Iss. 617
Open Access | Times Cited: 41
Passerini–Smiles Reaction of α‐Ketophosphonates: Platform for Phospha‐Brook/Smiles Embedded Cascades
Cristina Cheibas, Nicolás Fincias, Nicolas Casaretto, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 11
Closed Access | Times Cited: 23
Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis
Paul M. Burkat
Journal of Psychopharmacology (2025)
Closed Access
ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, et al.
British Journal of Pharmacology (2025)
Open Access
Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
Annika Frank, Dóra Kiss, György M. Keserü, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 33
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists
Francisco O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6287-6314
Open Access | Times Cited: 32
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Designing drugs and chemical probes with the dualsteric approach
Jinyin Zha, Jixiao He, Chengwei Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8651-8677
Closed Access | Times Cited: 9
Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors
Ana Semeano, Rian Garland, Alessandro Bonifazi, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2333-2349
Open Access | Times Cited: 3
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D 2 receptor
Christopher J. Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Biochemical Pharmacology (2018) Vol. 148, pp. 315-328
Open Access | Times Cited: 29
Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Michael L. Martini, Caroline Ray, Xufen Yu, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 9, pp. 4160-4182
Open Access | Times Cited: 27
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome
Mark J. Henderson, Kathleen A. Trychta, Shyh‐Ming Yang, et al.
Cell Reports (2021) Vol. 35, Iss. 4, pp. 109040-109040
Open Access | Times Cited: 22
Chemical biology of noncanonical G protein–coupled receptor signaling: Toward advanced therapeutics
Maria M. Shchepinova, Aylin C. Hanyaloglu, Gary Frost, et al.
Current Opinion in Chemical Biology (2020) Vol. 56, pp. 98-110
Closed Access | Times Cited: 21
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
Ravi Kumar Verma, Ara M. Abramyan, Mayako Michino, et al.
PLoS Computational Biology (2018) Vol. 14, Iss. 1, pp. e1005948-e1005948
Open Access | Times Cited: 21
Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists
Michael L. Martini, Jing Liu, Caroline Ray, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 7, pp. 3753-3772
Open Access | Times Cited: 20
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist
Amy E. Moritz, R. Benjamin Free, Warren S. Weiner, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 10, pp. 5526-5567
Open Access | Times Cited: 19
Post-ischemic administration of dopamine D2 receptor agonist reduces cell death by activating mitochondrial pathway following ischemic stroke
Pooja Kaushik, Mubashshir Ali, Heena Tabassum, et al.
Life Sciences (2020) Vol. 261, pp. 118349-118349
Closed Access | Times Cited: 19
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
Pramisha Adhikari, Bing Xie, Ana Semeano, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 570-570
Open Access | Times Cited: 16
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Marie Emilie Hovah, Ulrike Holzgrabe
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2545-2599
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top